Plasma IL‐6, plasma VEGF, and serum YKL‐40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate

Authors:

Abstract
(2006). Plasma IL‐6, plasma VEGF, and serum YKL‐40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate. Scandinavian Journal of Rheumatology: Vol. 35, No. 6, pp. 489-491.

This publication has 9 references indexed in Scilit: